GLP-1 drugs add something new to your system. Our technology enhances what’s already there,” Muchnick said. While NotCo’s ...

Right now, about 12% of American aged 18 or older (or 1 in 8 adults) are taking GLP-1 — glucagon-like peptide-1 — receptor ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

GLP-1 medications are changing the way we approach weight loss and chronic conditions. Dr. Nima Mowzoon of UBI Telehealth ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

In recent years, GLP-1 for weight loss has emerged as a significant breakthrough, capturing the attention of both healthcare providers and individuals struggling with obesity. Glucagon-like peptide-1 ...

With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

if they’ve been taking a compounded copy of a [GLP-1] drug, that era is coming to an end.” It’s a hard reality for patients to accept. Online, some wonder what’s different now, months after the ...

You may soon be able to eat your Ozempic … sort of. GLP-1 supplements are booming, promising to deliver similar benefits to Ozempic and Wegovy without the pricey injections. The latest contender ...